Back to Screener

Healthcare

Bicara Therapeutics Inc. Common Stock(BCAX)

Live Price

Offline

$26.87

+2.01% today

1Y Change

+187.03%

Window

Jun 27, 2025 โ†’ Jun 23, 2026

Market Cap
$1.27B
Revenue Growth
0.0%
EPS Growth
-101.6%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 27, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Bicara Therapeutics Inc. Common Stock (BCAX) is a Healthcare stock with a market cap of $1.27B. The stock last traded around $26.87 and up 187.0% across the available one-year price window (Jun 27, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -101.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -101.6%, free cash flow -43.2% with operating margin 0.0% and ROIC -38.6%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BCAX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BCAX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BCAX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BCAX Max Drawdown

-26.43%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BCAX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.64
โ€”
โ€”
Est โ€”
โ€”
May 12
โ€”
Mar 26, 26
โœ“
-0.68
Est -0.72
+5.6%
โ€”
Est โ€”
โ€”
Mar 26
โ€”
Nov 10, 25
โœ—
-0.67
Est -0.55
-21.8%
โ€”
Est โ€”
โ€”
Nov 10
โ€”
Aug 12, 25
โœ“
-0.50
Est -0.54
+7.4%
โ€”
Est โ€”
โ€”
Aug 12
โ€”
May 13, 25
โœ—
-0.68
Est -0.40
-70.0%
โ€”
Est โ€”
โ€”
May 13
โ€”
Mar 27, 25
โœ—
-0.39
Est -0.31
-25.8%
โ€”
Est โ€”
โ€”
Mar 27
โ€”
Nov 12, 24
โœ—
-1.60
Est -0.46
-247.8%
โ€”
Est โ€”
โ€”
Nov 12
โ€”
Sep 13, 24
-0.27
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 13
โ€”
Jun 30, 24
-0.27
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 23
-0.23
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 23
-0.42
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 23
-0.15
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 23
-0.15
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.